The value of vascular endothelial growth factor, pregnancy-associated plasma protein-A, and progesterone for early differentiation of ectopic pregnancies, normal intrauterine pregnancies, and spontaneous miscarriages

被引:25
|
作者
Ugurlu, Evin Nil [1 ]
Ozaksit, Gulnur [1 ]
Karaer, Abdullah [1 ]
Zulfikaroglu, Ebru [1 ]
Atalay, Aral [1 ]
Ugur, Mustafa [1 ]
机构
[1] Dr Zekai Tahir Burak Woman Hlth Educ & Res Hosp, Dept Obstet & Gynecol, Ankara, Turkey
关键词
Ectopic pregnancy; PAPP-A; sensitivity; specifity; VEGF; SINGLE SERUM PROGESTERONE; ABNORMAL INTRAUTERINE; FACTOR VEGF; PAPP-A; DIAGNOSIS; EXPRESSION; DISCRIMINATION; ESTRADIOL; ACCURACY; PLACENTA;
D O I
10.1016/j.fertnstert.2008.02.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the capacity of vascular endothelial growth factor (VEGF), pregnancy-associated plasma protein-A (PAPP-A), and progesterone (P) to discriminate ectopic pregnancies (EP) from nonectopic ones. Design: Prospective, case-controlled study. Setting: Tertiary care center. Patient(s): Twenty-nine women with EP, 29 women with normal intrauterine pregnancy (nIUP), and 28 women with spontaneous miscarriage, all matched for gestational age. Intervention(s): Serum samples were obtained. Main Outcome Measure(s): Serum concentrations of VEGF, PAPP-A, and P were measured. Result(s): Serum VEGF concentrations did not show statistically significant differences among women with EP (median, 55.24 pg/mL; range, 0.20-179.24), spontaneous miscarriages (median, 26.24 pg/mL; range, 0.22365.24), and nIUP (median, 43.24 pg/mL; range, 0.86-101.24). The median level of P was significantly increased in the nIUP group (20.58 ng/mL; range, 13.9-37.04) compared with the other two groups, but there was no statistically significant difference between the spontaneous miscarriage and EP groups. Like P, PAPP-A values were also significantly higher in the nIUP group than in the other two groups, but the difference between PAPP-A values in the EP and spontaneous abortion groups was statistically insignificant. Conclusion(s): VEGF, PAPP-A, and P cannot be used to diagnose EPs, but PAPP-A and P can at least be used to differentiate abnormal pregnancies. (Fertil Steril (R) 2009;91:1657-61. (C)2009 by American Society for Reproductive Medicine.)
引用
收藏
页码:1657 / 1661
页数:5
相关论文
共 50 条
  • [31] Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth
    Smith, GCS
    Stenhouse, EJ
    Crossley, JA
    Aitken, DA
    Cameron, AD
    Connor, JM
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1762 - 1767
  • [32] First-trimester prediction of preeclampsia: A comparison between Pregnancy-associated plasma protein-A and Placental growth factor
    Fillion, Alexandre
    Guerby, Paul
    Gasse, Cedric
    Audibert, Francois
    Boutin, Amelie
    Giguere, Yves
    Forest, Jean-Claude
    Chaillet, Nils
    Bujold, Emmanuel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S454 - S455
  • [33] Assessment of Fetal Growth Restriction in Pregnancies Complicated by Low Pregnancy Associated Plasma Protein-A on Routine First Trimester Aneuploidy Screening
    Laky, Christine A.
    Wehrum, Mark J.
    Cozzini, Genevieve R.
    Malkus, Herb
    Copel, Joshua A.
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 338A - 338A
  • [34] Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies
    Giorgetti, C.
    Vanden Meerschaut, F.
    De Roo, C.
    Saunier, O.
    Quarello, E.
    Hairion, D.
    Penaranda, G.
    Chabert-Orsini, V.
    De Sutter, P.
    HUMAN REPRODUCTION, 2013, 28 (10) : 2636 - 2642
  • [35] Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both
    Zumaeta, A. Mazer
    Wright, A.
    Syngelaki, A.
    Maritsa, V. A.
    Bardani, E.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 56 (03) : 408 - 415
  • [36] Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noel, L.
    Guy, G. P.
    Jones, S.
    Forenc, K.
    Buck, E.
    Papageorghiou, A. T.
    Thilaganathan, B.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (04) : 540 - 545
  • [37] Growth Differentiation Factor 15, Ischemia Modified Albumin and Pregnancy-Associated Plasma Protein A in Patients with Coronary Artery Disease
    Fan, Lie Ying
    Jin, Zhong Gan
    Zong, Ming
    Wang, Qing Zhong
    Ju, Yi
    Sun, Li Shan
    Gu, Yu Ying
    Yu, Ping
    Zhang, Dai Fu
    Liu, Zhong Min
    CLINICAL LABORATORY, 2014, 60 (06) : 973 - 982
  • [38] Comparison of First Trimester Screening for Down's Syndrome Using Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A Levels between Spontaneous and IVF Pregnancies at 12 Weeks of Gestation
    Taheripanah, Robabeh
    Talayeh, Maryam
    Zamaniyan, Marzieh
    Khosravi, Donya
    Taheripanah, Anahita
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2019, 13 (02) : 93 - 96
  • [39] Re: Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Cuckle, H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2022, 59 (03)
  • [40] Pregnancy-associated plasma protein-A and insulin-like growth factor binding protein mRNAs in granulosa cells of dominant and subordinate follicles of preovulatory cattle
    Santiago, CA
    Voge, JL
    Aad, PY
    Allen, DT
    Stein, DR
    Malayer, JR
    Spicer, LJ
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2005, 28 (01) : 46 - 63